# Merck to build new facility in Durham, North Carolina for TICE BCG

Merck announced plans to construct a new manufacturing facility at its Maurice R. Hilleman Center in Durham, North Carolina, to triple production capacity for TICE BCG bladder cancer medicine. Construction is expected to take 5-6 years.

- Type: Expansion
- Announced: 2021-01-27
- Where: Durham, North Carolina, United States
- Status: announced
- Capacity: triple current manufacturing capacity
- Products: TICE BCG (BCG Live for Intravesical Use)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Merck](https://endata.com/companies/1841.md)

## Sources

- [merck.com](https://www.merck.com/news/merck-to-construct-new-facility-in-the-united-states-to-expand-manufacturing-capacity-for-tice-bcg/), 2021-01-27: "Once this new facility is fully operational, we will triple the company’s current manufacturing capacity, which is expected to support the anticipated demand for TICE BCG for the foreseeable future."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.